Stephens Inc Becton Dickinson & CO Transaction History

Stephens Inc

$6.77 Billion
Q3 2024

A detailed history of Stephens Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Stephens Inc holds 18,029 shares of BDX stock, worth $4.09 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

18,029

Previous 18,757 3.88%

Holding current value

$4.09 Million

Previous $4.38 Million 0.84%

% of portfolio

0.06%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$221.47 - $242.41 $161,230 - $176,474	-728 Reduced 3.88%	18,029 $4.35 Million
Q2 2024 Aug 06, 2024	SELL	$225.07 - $246.17 $273,234 - $298,850	-1,214 Reduced 6.08%	18,757 $4.38 Million
Q1 2024 May 15, 2024	BUY	$233.45 - $247.73 $764,081 - $810,820	3,273 Added 19.6%	19,971 $4.94 Million
Q4 2023 Feb 13, 2024	BUY	$232.24 - $267.23 $685,804 - $789,130	2,953 Added 21.48%	16,698 $4.07 Million
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $175,881 - $195,677	-690 Reduced 4.78%	13,745 $3.55 Million
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $13,349 - $14,857	-56 Reduced 0.39%	14,435 $3.81 Million
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $80,628 - $91,031	351 Added 2.48%	14,491 $3.59 Million
Q4 2022 Jan 25, 2023	SELL	$218.29 - $256.91 $237,499 - $279,518	-1,088 Reduced 7.14%	14,140 $3.6 Million
Q3 2022 Nov 02, 2022	SELL	$51.03 - $264.23 $82,668 - $428,052	-1,620 Reduced 9.62%	15,228 $3.39 Million
Q2 2022 Aug 03, 2022	SELL	$234.74 - $275.42 $42,018 - $49,300	-179 Reduced 1.05%	16,848 $4.15 Million
Q1 2022 May 04, 2022	BUY	$243.64 - $270.48 $19,978 - $22,179	82 Added 0.48%	17,027 $4.53 Million
Q4 2021 Mar 07, 2022	SELL	$230.08 - $250.94 $468,903 - $511,415	-2,038 Reduced 10.74%	16,945 $4.26 Million
Q3 2021 Oct 27, 2021	SELL	$232.72 - $256.47 $339,538 - $374,189	-1,459 Reduced 7.14%	18,983 $4.67 Million
Q2 2021 Aug 12, 2021	BUY	$232.65 - $254.58 $531,605 - $581,715	2,285 Added 12.58%	20,442 $4.97 Million
Q1 2021 May 14, 2021	BUY	$232.09 - $256.88 $737,349 - $816,107	3,177 Added 21.21%	18,157 $4.42 Million
Q4 2020 Feb 10, 2021	BUY	$221.92 - $245.94 $738,105 - $817,996	3,326 Added 28.54%	14,980 $3.75 Million
Q3 2020 Nov 13, 2020	SELL	$215.77 - $276.76 $58,473 - $75,001	-271 Reduced 2.27%	11,654 $2.71 Million
Q2 2020 Aug 24, 2020	BUY	$219.9 - $263.41 $47,498 - $56,896	216 Added 1.84%	11,925 $2.85 Million
Q1 2020 May 14, 2020	BUY	$195.69 - $279.01 $285,316 - $406,796	1,458 Added 14.22%	11,709 $2.69 Million
Q4 2019 Feb 14, 2020	BUY	$236.45 - $266.82 $190,578 - $215,056	806 Added 8.53%	10,251 $2.79 Million
Q3 2019 Oct 18, 2019	BUY	$230.58 - $256.08 $158,408 - $175,926	687 Added 7.84%	9,445 $2.39 Million
Q2 2019 Aug 01, 2019	SELL	$217.4 - $246.08 $18,696 - $21,162	-86 Reduced 0.97%	8,758 $2.21 Million
Q1 2019 May 03, 2019	BUY	$206.05 - $248.17 $106,939 - $128,800	519 Added 6.23%	8,844 $2.21 Million
Q4 2018 Feb 11, 2019	SELL	$204.73 - $257.93 $398,404 - $501,931	-1,946 Reduced 18.95%	8,325 $1.88 Million
Q3 2018 Nov 14, 2018	BUY	$233.07 - $256.0 $27,735 - $30,464	119 Added 1.17%	10,271 $2.68 Million
Q2 2018 Aug 10, 2018	SELL	$208.1 - $233.85 $8,948 - $10,055	-43 Reduced 0.42%	10,152 $2.43 Million
Q1 2018 May 03, 2018	BUY	$205.46 - $240.27 $466,188 - $545,172	2,269 Added 28.63%	10,195 $2.21 Million
Q4 2017 Feb 05, 2018	BUY	$189.0 - $222.64 $52,353 - $61,671	277 Added 3.62%	7,926 $1.7 Million
Q3 2017 Nov 08, 2017	SELL	$186.89 - $198.9 $113,255 - $120,533	-606 Reduced 7.34%	7,649 $1.5 Million
Q2 2017 Aug 10, 2017	BUY	N/A	8,255	8,255 $1.61 Million

Others Institutions Holding BDX

# of Institutions

1,736

Shares Held

254M

Call Options Held

581K

Put Options Held

653K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.8B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account